IART Q3 Deep Dive: Supply Chain Progress, Product Relaunches, and Margin Pressures Shape Outlook

Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q3 CY2025, but sales ...